Ingelheim, Germany, 13/03/2025 Topline data from FIBRONEER™-ILD show that the investigational compound nerandomilast met…
Tag:
nerandomilast
-
-
Lifestyle & Healthslider
Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study
by Karine Ayoubby Karine AyoubIngelheim, Germany, Mon, 16/09/2024 – 12:00 Boehringer Ingelheim announced today that the FIBRONEER™-IPF trial…